GASTROINTEST ENDOSC 润色咨询

GASTROINTESTINAL ENDOSCOPY

出版年份:1965 年文章数:3497 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:14.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向:原创;内镜;临床<br>经验分享:前天投稿临床回顾性队列研究,昨天with editor,全程直播过程,求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向:内镜<br>经验分享:现在很慢啊?with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:内镜;临床<br>经验分享:之前投了一篇,一周就给结果了,推荐投子刊,又投一篇,快1月了,还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152755, encodeId=95902152e558c, content=偏重的研究方向:消化;内镜<br>经验分享:投稿了,给了建议投子刊iGIE,请问这个是SCI期刊吗?请前辈指教,这也是第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b03b8455906, createdName=ms2000000235984434, createdTime=Mon Aug 14 22:21:28 CST 2023, time=2023-08-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关?<span class="quote">158****1505暂无昵称 2019-11-24 00:00:00 发表:<br>被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。</span>, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:美国消化内镜协会会刊,是牛刊,八年制童鞋一枚,非常荣幸,中了一篇!2013-11-30投稿,2014-03-15接收。临床横断面研究。中间经历2次大修,1次小修。过程很艰辛,很辛苦~问题很专业,很刁钻,但编辑很好,非常友好~ 建议和态度很好!认真修改,态度要好,问题回答好,会有机会。之前我投了2篇,都被审稿后拒掉,没给回答问题的机会,灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神,With Editor一周,不知道是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家,GIE的具体要求和格式是什么?是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2021-09-14 120a6ac7m01(暂无昵称)

    偏重的研究方向:原创;内镜;临床
    经验分享:前天投稿临床回顾性队列研究,昨天with editor,全程直播过程,求好运吧!

    34

    展开34条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向:原创;内镜;临床<br>经验分享:前天投稿临床回顾性队列研究,昨天with editor,全程直播过程,求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向:内镜<br>经验分享:现在很慢啊?with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:内镜;临床<br>经验分享:之前投了一篇,一周就给结果了,推荐投子刊,又投一篇,快1月了,还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152755, encodeId=95902152e558c, content=偏重的研究方向:消化;内镜<br>经验分享:投稿了,给了建议投子刊iGIE,请问这个是SCI期刊吗?请前辈指教,这也是第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b03b8455906, createdName=ms2000000235984434, createdTime=Mon Aug 14 22:21:28 CST 2023, time=2023-08-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关?<span class="quote">158****1505暂无昵称 2019-11-24 00:00:00 发表:<br>被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。</span>, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:美国消化内镜协会会刊,是牛刊,八年制童鞋一枚,非常荣幸,中了一篇!2013-11-30投稿,2014-03-15接收。临床横断面研究。中间经历2次大修,1次小修。过程很艰辛,很辛苦~问题很专业,很刁钻,但编辑很好,非常友好~ 建议和态度很好!认真修改,态度要好,问题回答好,会有机会。之前我投了2篇,都被审稿后拒掉,没给回答问题的机会,灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神,With Editor一周,不知道是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家,GIE的具体要求和格式是什么?是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2023-07-10 fzdndx 来自江苏省

    偏重的研究方向:内镜
    经验分享:现在很慢啊?with editor 20天了

    6

    展开6条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向:原创;内镜;临床<br>经验分享:前天投稿临床回顾性队列研究,昨天with editor,全程直播过程,求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向:内镜<br>经验分享:现在很慢啊?with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:内镜;临床<br>经验分享:之前投了一篇,一周就给结果了,推荐投子刊,又投一篇,快1月了,还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152755, encodeId=95902152e558c, content=偏重的研究方向:消化;内镜<br>经验分享:投稿了,给了建议投子刊iGIE,请问这个是SCI期刊吗?请前辈指教,这也是第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b03b8455906, createdName=ms2000000235984434, createdTime=Mon Aug 14 22:21:28 CST 2023, time=2023-08-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关?<span class="quote">158****1505暂无昵称 2019-11-24 00:00:00 发表:<br>被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。</span>, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:美国消化内镜协会会刊,是牛刊,八年制童鞋一枚,非常荣幸,中了一篇!2013-11-30投稿,2014-03-15接收。临床横断面研究。中间经历2次大修,1次小修。过程很艰辛,很辛苦~问题很专业,很刁钻,但编辑很好,非常友好~ 建议和态度很好!认真修改,态度要好,问题回答好,会有机会。之前我投了2篇,都被审稿后拒掉,没给回答问题的机会,灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神,With Editor一周,不知道是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家,GIE的具体要求和格式是什么?是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2023-04-09 猫游记 来自四川省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:内镜;临床
    经验分享:之前投了一篇,一周就给结果了,推荐投子刊,又投一篇,快1月了,还在with editor,搞不懂

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向:原创;内镜;临床<br>经验分享:前天投稿临床回顾性队列研究,昨天with editor,全程直播过程,求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向:内镜<br>经验分享:现在很慢啊?with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:内镜;临床<br>经验分享:之前投了一篇,一周就给结果了,推荐投子刊,又投一篇,快1月了,还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152755, encodeId=95902152e558c, content=偏重的研究方向:消化;内镜<br>经验分享:投稿了,给了建议投子刊iGIE,请问这个是SCI期刊吗?请前辈指教,这也是第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b03b8455906, createdName=ms2000000235984434, createdTime=Mon Aug 14 22:21:28 CST 2023, time=2023-08-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关?<span class="quote">158****1505暂无昵称 2019-11-24 00:00:00 发表:<br>被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。</span>, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:美国消化内镜协会会刊,是牛刊,八年制童鞋一枚,非常荣幸,中了一篇!2013-11-30投稿,2014-03-15接收。临床横断面研究。中间经历2次大修,1次小修。过程很艰辛,很辛苦~问题很专业,很刁钻,但编辑很好,非常友好~ 建议和态度很好!认真修改,态度要好,问题回答好,会有机会。之前我投了2篇,都被审稿后拒掉,没给回答问题的机会,灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神,With Editor一周,不知道是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家,GIE的具体要求和格式是什么?是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2022-08-09 sky110319

    请教各位大神,alt reviewer invited是什么意思?

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向:原创;内镜;临床<br>经验分享:前天投稿临床回顾性队列研究,昨天with editor,全程直播过程,求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向:内镜<br>经验分享:现在很慢啊?with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:内镜;临床<br>经验分享:之前投了一篇,一周就给结果了,推荐投子刊,又投一篇,快1月了,还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152755, encodeId=95902152e558c, content=偏重的研究方向:消化;内镜<br>经验分享:投稿了,给了建议投子刊iGIE,请问这个是SCI期刊吗?请前辈指教,这也是第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b03b8455906, createdName=ms2000000235984434, createdTime=Mon Aug 14 22:21:28 CST 2023, time=2023-08-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关?<span class="quote">158****1505暂无昵称 2019-11-24 00:00:00 发表:<br>被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。</span>, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:美国消化内镜协会会刊,是牛刊,八年制童鞋一枚,非常荣幸,中了一篇!2013-11-30投稿,2014-03-15接收。临床横断面研究。中间经历2次大修,1次小修。过程很艰辛,很辛苦~问题很专业,很刁钻,但编辑很好,非常友好~ 建议和态度很好!认真修改,态度要好,问题回答好,会有机会。之前我投了2篇,都被审稿后拒掉,没给回答问题的机会,灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神,With Editor一周,不知道是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家,GIE的具体要求和格式是什么?是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2023-08-14 ms2000000235984434 来自北京

    偏重的研究方向:消化;内镜
    经验分享:投稿了,给了建议投子刊iGIE,请问这个是SCI期刊吗?请前辈指教,这也是第一次投

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向:原创;内镜;临床<br>经验分享:前天投稿临床回顾性队列研究,昨天with editor,全程直播过程,求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向:内镜<br>经验分享:现在很慢啊?with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:内镜;临床<br>经验分享:之前投了一篇,一周就给结果了,推荐投子刊,又投一篇,快1月了,还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152755, encodeId=95902152e558c, content=偏重的研究方向:消化;内镜<br>经验分享:投稿了,给了建议投子刊iGIE,请问这个是SCI期刊吗?请前辈指教,这也是第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b03b8455906, createdName=ms2000000235984434, createdTime=Mon Aug 14 22:21:28 CST 2023, time=2023-08-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关?<span class="quote">158****1505暂无昵称 2019-11-24 00:00:00 发表:<br>被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。</span>, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:美国消化内镜协会会刊,是牛刊,八年制童鞋一枚,非常荣幸,中了一篇!2013-11-30投稿,2014-03-15接收。临床横断面研究。中间经历2次大修,1次小修。过程很艰辛,很辛苦~问题很专业,很刁钻,但编辑很好,非常友好~ 建议和态度很好!认真修改,态度要好,问题回答好,会有机会。之前我投了2篇,都被审稿后拒掉,没给回答问题的机会,灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神,With Editor一周,不知道是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家,GIE的具体要求和格式是什么?是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2019-12-03 123eca1fm35暂无昵称

    这是是不是必须和内镜有关?158****1505暂无昵称 2019-11-24 00:00:00 发表:
    被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。

    158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向:原创;内镜;临床<br>经验分享:前天投稿临床回顾性队列研究,昨天with editor,全程直播过程,求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向:内镜<br>经验分享:现在很慢啊?with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:内镜;临床<br>经验分享:之前投了一篇,一周就给结果了,推荐投子刊,又投一篇,快1月了,还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152755, encodeId=95902152e558c, content=偏重的研究方向:消化;内镜<br>经验分享:投稿了,给了建议投子刊iGIE,请问这个是SCI期刊吗?请前辈指教,这也是第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b03b8455906, createdName=ms2000000235984434, createdTime=Mon Aug 14 22:21:28 CST 2023, time=2023-08-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关?<span class="quote">158****1505暂无昵称 2019-11-24 00:00:00 发表:<br>被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。</span>, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:美国消化内镜协会会刊,是牛刊,八年制童鞋一枚,非常荣幸,中了一篇!2013-11-30投稿,2014-03-15接收。临床横断面研究。中间经历2次大修,1次小修。过程很艰辛,很辛苦~问题很专业,很刁钻,但编辑很好,非常友好~ 建议和态度很好!认真修改,态度要好,问题回答好,会有机会。之前我投了2篇,都被审稿后拒掉,没给回答问题的机会,灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神,With Editor一周,不知道是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家,GIE的具体要求和格式是什么?是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2014-03-15 qwg19912844

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:美国消化内镜协会会刊,是牛刊,八年制童鞋一枚,非常荣幸,中了一篇!2013-11-30投稿,2014-03-15接收。临床横断面研究。中间经历2次大修,1次小修。过程很艰辛,很辛苦~问题很专业,很刁钻,但编辑很好,非常友好~ 建议和态度很好!认真修改,态度要好,问题回答好,会有机会。之前我投了2篇,都被审稿后拒掉,没给回答问题的机会,灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向:原创;内镜;临床<br>经验分享:前天投稿临床回顾性队列研究,昨天with editor,全程直播过程,求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向:内镜<br>经验分享:现在很慢啊?with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:内镜;临床<br>经验分享:之前投了一篇,一周就给结果了,推荐投子刊,又投一篇,快1月了,还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152755, encodeId=95902152e558c, content=偏重的研究方向:消化;内镜<br>经验分享:投稿了,给了建议投子刊iGIE,请问这个是SCI期刊吗?请前辈指教,这也是第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b03b8455906, createdName=ms2000000235984434, createdTime=Mon Aug 14 22:21:28 CST 2023, time=2023-08-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关?<span class="quote">158****1505暂无昵称 2019-11-24 00:00:00 发表:<br>被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。</span>, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:美国消化内镜协会会刊,是牛刊,八年制童鞋一枚,非常荣幸,中了一篇!2013-11-30投稿,2014-03-15接收。临床横断面研究。中间经历2次大修,1次小修。过程很艰辛,很辛苦~问题很专业,很刁钻,但编辑很好,非常友好~ 建议和态度很好!认真修改,态度要好,问题回答好,会有机会。之前我投了2篇,都被审稿后拒掉,没给回答问题的机会,灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神,With Editor一周,不知道是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家,GIE的具体要求和格式是什么?是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2023-07-31 天元湖大鲤鱼 来自江苏省

    各位decision in process一般持续多久?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向:原创;内镜;临床<br>经验分享:前天投稿临床回顾性队列研究,昨天with editor,全程直播过程,求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向:内镜<br>经验分享:现在很慢啊?with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:内镜;临床<br>经验分享:之前投了一篇,一周就给结果了,推荐投子刊,又投一篇,快1月了,还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152755, encodeId=95902152e558c, content=偏重的研究方向:消化;内镜<br>经验分享:投稿了,给了建议投子刊iGIE,请问这个是SCI期刊吗?请前辈指教,这也是第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b03b8455906, createdName=ms2000000235984434, createdTime=Mon Aug 14 22:21:28 CST 2023, time=2023-08-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关?<span class="quote">158****1505暂无昵称 2019-11-24 00:00:00 发表:<br>被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。</span>, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:美国消化内镜协会会刊,是牛刊,八年制童鞋一枚,非常荣幸,中了一篇!2013-11-30投稿,2014-03-15接收。临床横断面研究。中间经历2次大修,1次小修。过程很艰辛,很辛苦~问题很专业,很刁钻,但编辑很好,非常友好~ 建议和态度很好!认真修改,态度要好,问题回答好,会有机会。之前我投了2篇,都被审稿后拒掉,没给回答问题的机会,灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神,With Editor一周,不知道是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家,GIE的具体要求和格式是什么?是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2022-07-21 sky110319

    请教各位大神,With Editor一周,不知道是什么情况?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1050205, encodeId=c5cc105020544, content=偏重的研究方向:原创;内镜;临床<br>经验分享:前天投稿临床回顾性队列研究,昨天with editor,全程直播过程,求好运吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Sep 14 09:37:08 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147224, encodeId=3682214e224f8, content=偏重的研究方向:内镜<br>经验分享:现在很慢啊?with editor 20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Mon Jul 10 07:16:52 CST 2023, time=2023-07-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2124587, encodeId=fffc212458eaf, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:内镜;临床<br>经验分享:之前投了一篇,一周就给结果了,推荐投子刊,又投一篇,快1月了,还在with editor,搞不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/d76MWuicTRerBNPNwNoSbFQ9Po7qvwEA5qWLEl1knwyfZicsfvYkspXicEgibG79vdc3H9D6LzmrRPkRTIApKRWibPA/132, createdBy=84af5256921, createdName=猫游记, createdTime=Sun Apr 09 14:24:40 CST 2023, time=2023-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152755, encodeId=95902152e558c, content=偏重的研究方向:消化;内镜<br>经验分享:投稿了,给了建议投子刊iGIE,请问这个是SCI期刊吗?请前辈指教,这也是第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b03b8455906, createdName=ms2000000235984434, createdTime=Mon Aug 14 22:21:28 CST 2023, time=2023-08-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=580865, encodeId=356b58086553, content=这是是不是必须和内镜有关?<span class="quote">158****1505暂无昵称 2019-11-24 00:00:00 发表:<br>被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。</span>, beContent=158****1505暂无昵称 2019-11-24 00:00:00 发表: 被AJG拒稿,按照审稿意见仔细修改,改投GIE一审一个多月,大修返修后大概20天直接接收,article,mark一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501754, encodeId=3584501e5485, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:美国消化内镜协会会刊,是牛刊,八年制童鞋一枚,非常荣幸,中了一篇!2013-11-30投稿,2014-03-15接收。临床横断面研究。中间经历2次大修,1次小修。过程很艰辛,很辛苦~问题很专业,很刁钻,但编辑很好,非常友好~ 建议和态度很好!认真修改,态度要好,问题回答好,会有机会。之前我投了2篇,都被审稿后拒掉,没给回答问题的机会,灰常伤心。终于上了一篇。嘿嘿嘿~大家都加油哈~ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9082523, createdName=qwg19912844, createdTime=Sat Mar 15 07:32:00 CST 2014, time=2014-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150698, encodeId=6fea2150698c0, content=各位decision in process一般持续多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/C330BE00144576C6742F870B2385E70A/100, createdBy=7fca2434689, createdName=天元湖大鲤鱼, createdTime=Mon Jul 31 23:32:34 CST 2023, time=2023-07-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1233866, encodeId=e74112338661f, content=请教各位大神,With Editor一周,不知道是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Thu Jul 21 16:55:19 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211437, encodeId=6685121143e7c, content=想问一下大家,GIE的具体要求和格式是什么?是要注册登录才能看吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Apr 15 14:30:47 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2022-04-15 ms6000000285996390

    想问一下大家,GIE的具体要求和格式是什么?是要注册登录才能看吗

    1

    展开1条回复
共93条页码: 1/10页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分